8-K current report · filed Jul 29, 2026

CONMED Corp (CNMD) 8-K Current Report: July 29, 2026

Item EX-99.1Item 2.02CNMD overview

Short answer

CONMED Corp (CNMD) filed an 8-K current report with the SEC on July 29, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). CONMED reported fiscal second-quarter results for the period ended June 30, 2026.

CONMED Corp 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • CONMED reported fiscal second-quarter results for the period ended June 30, 2026
  • Press release issued July 29, 2026, with detailed financial results in Exhibit 99.1

Item EX-99.1 · Exhibit EX-99.1

  • Q2 sales $343.5M, up 0.3% reported but down 0.5% constant currency, reflecting GI exits and portfolio restructuring
  • Organic constant-currency sales grew 6.0%, led by Orthopedic Surgery and international growth of 9.9%
  • Adjusted diluted EPS $1.38, up 20.0%, while GAAP EPS reached $0.77, up 11.6%, including $0.21 tariff-refund benefit
  • Gross margin expanded to 57.5% from 55.0%, but operating margin declined to 10.6% from 11.1% amid transition and rationalization costs
  • Full-year adjusted EPS guidance raised to $4.48-$4.60 from $4.30-$4.45, while sales guidance narrowed to $1,358M-$1,373M

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other CONMED Corp 8-K filings

Get the next CNMD 8-K as it lands

Follow CNMD for push alerts, or ask the research agent what this filing means.